Jump to main content

TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 2 years of age.

Site search icon.
Mobile navigation icon.

TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 2 years of age.

3,250+ adolescents and adults have been prescribed TAKHZYRO since 2018*

Every person with hereditary angioedema (HAE) has a story to share. See how these people are choosing to reimagine their lives with TAKHZYRO. Individual experiences may vary.

*Based on third-party US specialty pharmacy data.